SCHEMBL3651724

SCHEMBL3651724

CCCN(C)Cc1c(-c2ccccc2)nc2cc(C=C(O)C(N)=O)ccn12

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 18/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3651719 1.00 HDAC1 (0.62) HDAC1
SCHEMBL3504088 0.81 HDAC1 (0.90) HDAC1
SCHEMBL3504086 0.81 HDAC1 (0.90) HDAC1
SCHEMBL3548314 0.76 HDAC1 (1.00) HDAC1
SCHEMBL3548312 0.76 HDAC1 (1.00) HDAC1
SCHEMBL28628801 0.76 NPC1 (0.60) HDAC1
SCHEMBL3547842 0.72 HDAC1 (1.00) HDAC1
SCHEMBL3547846 0.72 HDAC1 (1.00) HDAC1
SCHEMBL3550877 0.70 HDAC1 (1.00) HDAC1
SCHEMBL3550875 0.70 HDAC1 (1.00) HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2195029-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES Oryzon Genomics SA (ES) 2010-06-16 — — EP disclosed
WO-2009027349-A2 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS SA (ES) 2009-03-05 — — WO disclosed
Send feedback